文献速递耳科与耳神经鼻科咽喉与嗓音

2003-2019年美国食品药品监督管理局批准的中高风险耳鼻咽喉科器械的召回情况

Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019.
PubMed 文献 · Otolaryngol Head Neck Surg · 2022-03-15

该回顾性横断面分析查询FDA耳鼻咽喉科器械专家组数据库,分析1976-2019年510(k)与PMA审批及2003-2019年召回事件。共1061件(57.8%)510(k)和778件(42.3%)PMA申请获批。510(k)器械召回120次(11.3%)涉及42种器械,PMA器械召回25次(3.2%)涉及5种器械;510(k)审批器械召回比值比为3.67(95%CI 2.38-5.88,P<.0001)。

要点

  • 510(k)审批器械比PMA审批器械更易被召回,OR 3.67(95%CI 2.38-5.88,P<.0001)。
  • 510(k)手术器械比诊断器械更易被召回,OR 2.1(95%CI 1.1-4.4,P=.03)。
  • 召回器械中喉科占70.0%,普通耳鼻咽喉科占25.0%。

核心结论

  • 经510(k)途径批准的耳鼻咽喉科器械召回数量高于PMA途径。
  • 鉴于监管与促进创新之间的平衡,上市后监测和持续监管改进对确保医疗器械最佳安全性至关重要。

研究设计与样本

  • 回顾性横断面分析,数据来源于FDA公开数据库。
  • 查询FDA耳鼻咽喉科器械专家组数据库1976至2019年的510(k)许可和PMA批准。
  • 审查2003至2019年的器械召回,按亚专科、类型、支持证据和PMA补充类型分类。
  • 采用逻辑回归分析各器械类型和亚专科的召回比值比。

主要发现

  • 共批准1061件(57.8%)510(k)和778件(42.3%)PMA器械申请及修改。
  • 510(k)途径器械发生120次(11.3%)召回事件,涉及42种器械;PMA途径器械发生25次(3.2%)召回事件,涉及5种器械。
  • 510(k)器械审批比PMA器械审批更易被召回(OR 3.67;95%CI 2.38-5.88;P<.0001)。
  • 510(k)手术器械比诊断器械更易被召回(OR 2.1;95%CI 1.1-4.4;P=.03)。
  • 召回器械中喉科占70.0%,普通耳鼻咽喉科占25.0%。

关键数值与推荐

  • 510(k)审批器械召回比值比OR 3.67(95%CI 2.38-5.88;P<.0001)。
  • 510(k)手术器械召回比值比OR 2.1(95%CI 1.1-4.4;P=.03)。
  • 召回事件亚专科分布:喉科70.0%,普通耳鼻咽喉科25.0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The US Food and Drug Administration (FDA) regulates the marketing of medical devices based on the premarket approval (PMA) or 510(k) pathway. We investigated the relationship among the regulatory pathway of otolaryngologic devices, the number of recalls, and the recall characteristics. STUDY DESIGN: Retrospective cross-sectional analysis. SETTING: Publicly available FDA databases. METHODS: The FDA Ear, Nose, and Throat Devices Panel database was queried for 510(k) clearances and PMA approvals from 1976 to 2019. Device recalls from 2003 to 2019 were reviewed. Devices were then categorized by subspecialty, type, supporting evidence, and PMA supplement type. Logistic regression characterized the odds of recall for each device type and subspeciality. RESULTS: A total of 1061 (57.8%) 510(k) and 778 (42.3%) PMA device applications and modifications were approved. There were 120 (11.3%) recall events associated with 42 unique otolaryngologic devices cleared via the 510(k) pathway, as compared with 25 (3.2%) recall events for 5 unique PMA devices. 510(k) device approvals were more likely to be recalled than PMA device approvals (odds ratio, 3.67; 95% CI, 2.38-5.88; P < .0001). 510(k) surgical devices (odds ratio, 2.1; 95% CI, 1.1-4.4; P = .03) were more likely to be recalled than diagnostic devices. Devices designated for laryngology (70.0%) and general otolaryngology (25.0%) composed the majority of recalls. CONCLUSION: Otolaryngologic devices approved by the FDA via the 510(k) pathway exhibit a higher number of recalls than the PMA pathway. Given the balance between regulation and facilitating innovation, postmarket surveillance and ongoing regulatory improvements are critical to ensure optimal safety of medical devices.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Talati IA, Parsa KM, Gao WZ, et al. Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019. Otolaryngol Head Neck Surg. 2022. PMID: 35290135. doi:10.1177/01945998221085166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。